These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15049332)
1. Reducing mortality in patients with advanced cardiovascular disease: subgroups, subgroups and more subgroups.. Saksena S J Interv Card Electrophysiol; 2004 Feb; 10(1):7-8. PubMed ID: 15049332 [No Abstract] [Full Text] [Related]
2. Yes to cardiac devices. But at what cost? Leyva F Europace; 2013 Mar; 15(3):313-4. PubMed ID: 23243130 [No Abstract] [Full Text] [Related]
3. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? Josephson M; Nisam S Am J Cardiol; 1996 Apr; 77(10):859-63. PubMed ID: 8623740 [No Abstract] [Full Text] [Related]
4. Pharmacoeconomic considerations in antiarrhythmic therapy. Podrid PJ; Arnold RJ; Kaniecki DJ Pharmacoeconomics; 1992 Dec; 2(6):456-67. PubMed ID: 10147006 [TBL] [Abstract][Full Text] [Related]
5. What costs matter? Rethinking social costs of new device technologies. Choby AA; Clark AM Europace; 2013 Nov; 15(11):1538-9. PubMed ID: 23833047 [No Abstract] [Full Text] [Related]
6. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness. Groeneveld PW; Dixit S Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence. Lynd LD; O'Brien BJ J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S99-103. PubMed ID: 12950529 [TBL] [Abstract][Full Text] [Related]
8. The high cost of implantable defibrillators. Hlatky MA; Mark DB Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689 [TBL] [Abstract][Full Text] [Related]
9. [Remote monitoring of implantable cardiac devices: health technology assessment ]. Ricci RP; Locati ET; Campana A; Cavallaro C; Giammaria M; Landolina M; Marzegalli M; Melissano D G Ital Cardiol (Rome); 2015 May; 16(5):295-303. PubMed ID: 25994466 [TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of the implantable cardioverter-defibrillator: better in higher-risk patients and extended duration. Amsterdam EA Prev Cardiol; 2006; 9(3):131-2. PubMed ID: 16849874 [No Abstract] [Full Text] [Related]
12. Sudden death prevention with implantable devices. Passman R; Kadish A Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385 [No Abstract] [Full Text] [Related]
13. New device indications: practice and cost implications in Europe. Morgan JM; ; Card Electrophysiol Rev; 2003 Jan; 7(1):49-53. PubMed ID: 12766518 [TBL] [Abstract][Full Text] [Related]
14. [Interventional therapy of cardiac arrhythmias]. Pfeiffer D Dtsch Med Wochenschr; 2000 Apr; 125(16):506-7. PubMed ID: 10819013 [No Abstract] [Full Text] [Related]
15. Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre. Fanourgiakis J; Simantirakis E; Maniadakis N; Kourlaba G; Kanoupakis E; Chrysostomakis S; Vardas P Europace; 2013 Mar; 15(3):366-75. PubMed ID: 23148117 [TBL] [Abstract][Full Text] [Related]
16. Should we afford implantable cardioverter defibrillator therapy? Camm AJ Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):59. PubMed ID: 16265354 [No Abstract] [Full Text] [Related]
17. Arrhythmias in 2015: Advances in drug, ablation, and device therapy for cardiac arrhythmias. Macle L; Nattel S Nat Rev Cardiol; 2016 Feb; 13(2):67-8. PubMed ID: 26727299 [No Abstract] [Full Text] [Related]